IRF9 antibody (AA 1-393)
Quick Overview for IRF9 antibody (AA 1-393) (ABIN564508)
Target
See all IRF9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1-393
-
Purpose
- Mouse monoclonal antibody raised against a full length recombinant ISGF3G.
-
Sequence
- MASGRARCTR KLRNWVVEQV ESGQFPGVCW DDTAKTMFRI PWKHAGKQDF REDQDAAFFK AWAIFKGKYK EGDTGGPAVW KTRLRCALNK SSEFKEVPER GRMDVAEPYK VYQLLPPGIV SGQPGTQKVP SKRQHSSVSS ERKEEEDAMQ NCTLSPSVLQ DSLNNEEEGA SGGAVHSDIG SSSSSSSPEP QEVTDTTEAP FQGDQRSLEF LLPPEPDYSL LLTFIYNGRV VGEAQVQSLD CRLVAEPSGS ESSMEQVLFP KPGPLEPTQR LLSQLERGIL VASNPRGLFV QRLCPIPISW NAPQAPPGPG PHLLPSNECV ELFRTAYFCR DLVRYFQGLG PPPKFQVTLN FWEESHGSSH TPQNLITVKM EQAFARYLLE QTPEQQAAIL SLV
-
Cross-Reactivity
- Human
-
Characteristics
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- ISGF3G (AAH35716, 1 a.a. ~ 393 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handling Advice
- Aliquot to avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway." in: Clinical and experimental immunology, Vol. 178, Issue 3, pp. 548-60, (2014) (PubMed).
-
: "Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway." in: Clinical and experimental immunology, Vol. 178, Issue 3, pp. 548-60, (2014) (PubMed).
-
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
-
Alternative Name
- IRF9
-
Background
-
Full Gene Name: interferon regulatory factor 9
Synonyms: IRF-9,ISGF3,ISGF3G,p48 -
Gene ID
- 10379
-
Pathways
- JAK-STAT Signaling, Interferon-gamma Pathway, Hepatitis C
Target
-